| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | viral life cycle | 1.48e-04 | 340 | 7 | 3 | GO:0019058 | |
| GeneOntologyBiologicalProcess | defense response to virus | 1.51e-04 | 342 | 7 | 3 | GO:0051607 | |
| GeneOntologyBiologicalProcess | innate immune response | 2.40e-04 | 1092 | 7 | 4 | GO:0045087 | |
| GeneOntologyBiologicalProcess | response to virus | 2.86e-04 | 425 | 7 | 3 | GO:0009615 | |
| GeneOntologyBiologicalProcess | viral process | 3.70e-04 | 464 | 7 | 3 | GO:0016032 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 3.90e-04 | 90 | 7 | 2 | GO:0098586 | |
| GeneOntologyBiologicalProcess | regulation of viral genome replication | 3.99e-04 | 91 | 7 | 2 | GO:0045069 | |
| GeneOntologyBiologicalProcess | defense response to symbiont | 4.52e-04 | 1286 | 7 | 4 | GO:0140546 | |
| GeneOntologyBiologicalProcess | defense response to other organism | 6.38e-04 | 1407 | 7 | 4 | GO:0098542 | |
| GeneOntologyBiologicalProcess | viral genome replication | 9.00e-04 | 137 | 7 | 2 | GO:0019079 | |
| GeneOntologyBiologicalProcess | regulation of viral life cycle | 1.16e-03 | 156 | 7 | 2 | GO:1903900 | |
| GeneOntologyBiologicalProcess | regulation of viral process | 1.65e-03 | 186 | 7 | 2 | GO:0050792 | |
| Domain | TPR_8 | 7.49e-07 | 53 | 7 | 3 | PF13181 | |
| Domain | TPR_1 | 3.73e-06 | 90 | 7 | 3 | PF00515 | |
| Domain | TPR_1 | 3.73e-06 | 90 | 7 | 3 | IPR001440 | |
| Domain | TPR | 1.10e-05 | 129 | 7 | 3 | SM00028 | |
| Domain | TPR_repeat | 1.21e-05 | 133 | 7 | 3 | IPR019734 | |
| Domain | TPR-contain_dom | 1.74e-05 | 150 | 7 | 3 | IPR013026 | |
| Domain | TPR | 2.31e-05 | 165 | 7 | 3 | PS50005 | |
| Domain | TPR_REGION | 2.31e-05 | 165 | 7 | 3 | PS50293 | |
| Domain | - | 4.54e-05 | 207 | 7 | 3 | 1.25.40.10 | |
| Domain | TPR-like_helical_dom | 6.46e-05 | 233 | 7 | 3 | IPR011990 | |
| Domain | TPR_2 | 1.46e-04 | 50 | 7 | 2 | PF07719 | |
| Domain | TPR_2 | 1.46e-04 | 50 | 7 | 2 | IPR013105 | |
| Pathway | WP_COVID19_STRUCTURAL_COVERAGE_MAP | 4.88e-05 | 26 | 6 | 2 | M48318 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 4.47e-04 | 78 | 6 | 2 | M973 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 1.35e-03 | 136 | 6 | 2 | M42547 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 5.32e-03 | 273 | 6 | 2 | M983 | |
| Pubmed | 1.29e-04 | 547 | 7 | 3 | 37267103 | ||
| Interaction | TGM2 interactions | 5.29e-05 | 235 | 7 | 3 | int:TGM2 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 8.61e-06 | 115 | 7 | 3 | 769 | |
| Coexpression | GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP | 1.28e-05 | 190 | 7 | 3 | M7537 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN | 1.39e-05 | 195 | 7 | 3 | M4292 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN | 1.41e-05 | 196 | 7 | 3 | M9590 | |
| Coexpression | GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.41e-05 | 196 | 7 | 3 | M5349 | |
| Coexpression | GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.41e-05 | 196 | 7 | 3 | M5337 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN | 1.41e-05 | 196 | 7 | 3 | M4267 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN | 1.43e-05 | 197 | 7 | 3 | M9580 | |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 1.43e-05 | 197 | 7 | 3 | M7545 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | 1.43e-05 | 197 | 7 | 3 | M7543 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN | 1.43e-05 | 197 | 7 | 3 | M4294 | |
| Coexpression | GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP | 1.43e-05 | 197 | 7 | 3 | M3307 | |
| Coexpression | GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 1.45e-05 | 198 | 7 | 3 | M8969 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN | 1.45e-05 | 198 | 7 | 3 | M4264 | |
| Coexpression | GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN | 1.45e-05 | 198 | 7 | 3 | M3302 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 1.48e-05 | 199 | 7 | 3 | M8971 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 1.48e-05 | 199 | 7 | 3 | M4635 | |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN | 1.48e-05 | 199 | 7 | 3 | M6837 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN | 1.50e-05 | 200 | 7 | 3 | M7595 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN | 1.50e-05 | 200 | 7 | 3 | M9586 | |
| Coexpression | GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 1.50e-05 | 200 | 7 | 3 | M7618 | |
| Coexpression | GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN | 1.50e-05 | 200 | 7 | 3 | M3288 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP | 1.50e-05 | 200 | 7 | 3 | M8972 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN | 1.50e-05 | 200 | 7 | 3 | M3279 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 1.50e-05 | 200 | 7 | 3 | M8967 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN | 1.50e-05 | 200 | 7 | 3 | M7750 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN | 1.50e-05 | 200 | 7 | 3 | M4269 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP | 1.50e-05 | 200 | 7 | 3 | M9629 | |
| Coexpression | EINAV_INTERFERON_SIGNATURE_IN_CANCER | 2.14e-05 | 27 | 7 | 2 | M5091 | |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP | 9.98e-05 | 378 | 7 | 3 | M34022 | |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_2D_UP | 1.42e-04 | 69 | 7 | 2 | M4242 | |
| Coexpression | BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE | 1.82e-04 | 78 | 7 | 2 | M2532 | |
| Coexpression | STEIN_ESRRA_TARGETS | 2.69e-04 | 529 | 7 | 3 | M843 | |
| Coexpression | HALLMARK_INTERFERON_ALPHA_RESPONSE | 2.81e-04 | 97 | 7 | 2 | M5911 | |
| Coexpression | DER_IFN_BETA_RESPONSE_UP | 3.17e-04 | 103 | 7 | 2 | M13453 | |
| Coexpression | ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP | 4.23e-04 | 119 | 7 | 2 | M41139 | |
| Coexpression | HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 4.23e-04 | 119 | 7 | 2 | M41109 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP | 4.80e-04 | 644 | 7 | 3 | M34026 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 7.62e-04 | 160 | 7 | 2 | M8664 | |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | 8.00e-04 | 164 | 7 | 2 | M5653 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 8.60e-04 | 170 | 7 | 2 | M5657 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 8.70e-04 | 171 | 7 | 2 | M5655 | |
| Coexpression | KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN | 1.03e-03 | 186 | 7 | 2 | M1993 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN | 1.06e-03 | 189 | 7 | 2 | M4261 | |
| Coexpression | GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 1.06e-03 | 189 | 7 | 2 | M7539 | |
| Coexpression | GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP | 1.08e-03 | 191 | 7 | 2 | M4916 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN | 1.08e-03 | 191 | 7 | 2 | M4222 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP | 1.11e-03 | 193 | 7 | 2 | M9233 | |
| Coexpression | GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN | 1.12e-03 | 194 | 7 | 2 | M6082 | |
| Coexpression | GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN | 1.12e-03 | 194 | 7 | 2 | M9876 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN | 1.13e-03 | 195 | 7 | 2 | M9813 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN | 1.13e-03 | 195 | 7 | 2 | M4279 | |
| Coexpression | GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN | 1.13e-03 | 195 | 7 | 2 | M5142 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP | 1.14e-03 | 196 | 7 | 2 | M41141 | |
| Coexpression | GSE3982_MAST_CELL_VS_BCELL_DN | 1.15e-03 | 197 | 7 | 2 | M5437 | |
| Coexpression | ERBB2_UP.V1_DN | 1.15e-03 | 197 | 7 | 2 | M2635 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN | 1.15e-03 | 197 | 7 | 2 | M6835 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN | 1.16e-03 | 198 | 7 | 2 | M3401 | |
| Coexpression | GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN | 1.16e-03 | 198 | 7 | 2 | M5448 | |
| Coexpression | GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.16e-03 | 198 | 7 | 2 | M5341 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN | 1.16e-03 | 198 | 7 | 2 | M4272 | |
| Coexpression | GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN | 1.16e-03 | 198 | 7 | 2 | M3296 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP | 1.17e-03 | 199 | 7 | 2 | M6131 | |
| Coexpression | GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP | 1.17e-03 | 199 | 7 | 2 | M9306 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 1.17e-03 | 199 | 7 | 2 | M9568 | |
| Coexpression | GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN | 1.17e-03 | 199 | 7 | 2 | M8481 | |
| Coexpression | GSE3982_CTRL_VS_LPS_4H_MAC_DN | 1.17e-03 | 199 | 7 | 2 | M5368 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN | 1.17e-03 | 199 | 7 | 2 | M9970 | |
| Coexpression | GSE14000_UNSTIM_VS_4H_LPS_DC_DN | 1.17e-03 | 199 | 7 | 2 | M3347 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.19e-03 | 200 | 7 | 2 | M9358 | |
| Coexpression | GSE34006_WT_VS_A2AR_KO_TREG_DN | 1.19e-03 | 200 | 7 | 2 | M9042 | |
| Coexpression | GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP | 1.19e-03 | 200 | 7 | 2 | M9030 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN | 1.19e-03 | 200 | 7 | 2 | M3408 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN | 1.19e-03 | 200 | 7 | 2 | M3405 | |
| Coexpression | GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP | 1.19e-03 | 200 | 7 | 2 | M9051 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN | 1.19e-03 | 200 | 7 | 2 | M3638 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN | 1.19e-03 | 200 | 7 | 2 | M3635 | |
| Coexpression | GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN | 1.19e-03 | 200 | 7 | 2 | M8781 | |
| Coexpression | GSE10325_MYELOID_VS_LUPUS_MYELOID_DN | 1.19e-03 | 200 | 7 | 2 | M3097 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP | 1.19e-03 | 200 | 7 | 2 | M8690 | |
| Coexpression | HALLMARK_INTERFERON_GAMMA_RESPONSE | 1.19e-03 | 200 | 7 | 2 | M5913 | |
| Coexpression | GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN | 1.19e-03 | 200 | 7 | 2 | M8225 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN | 1.19e-03 | 200 | 7 | 2 | M9588 | |
| Coexpression | GSE42021_TREG_VS_TCONV_PLN_UP | 1.19e-03 | 200 | 7 | 2 | M9572 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN | 1.19e-03 | 200 | 7 | 2 | M9570 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN | 1.19e-03 | 200 | 7 | 2 | M9576 | |
| Coexpression | GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP | 1.19e-03 | 200 | 7 | 2 | M3142 | |
| Coexpression | KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP | 1.19e-03 | 200 | 7 | 2 | M3014 | |
| Coexpression | GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 1.19e-03 | 200 | 7 | 2 | M7613 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN | 1.19e-03 | 200 | 7 | 2 | M6789 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 1.19e-03 | 200 | 7 | 2 | M7320 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP | 1.19e-03 | 200 | 7 | 2 | M8657 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP | 1.19e-03 | 200 | 7 | 2 | M7322 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_UP | 1.19e-03 | 200 | 7 | 2 | M8775 | |
| Coexpression | GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN | 1.19e-03 | 200 | 7 | 2 | M7671 | |
| Coexpression | GSE22886_CTRL_VS_LPS_24H_DC_DN | 1.19e-03 | 200 | 7 | 2 | M4520 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN | 1.19e-03 | 200 | 7 | 2 | M6980 | |
| Coexpression | GSE14000_UNSTIM_VS_16H_LPS_DC_DN | 1.19e-03 | 200 | 7 | 2 | M3350 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP | 1.42e-03 | 219 | 7 | 2 | M41142 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | 1.79e-03 | 1012 | 7 | 3 | M40868 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP | 2.50e-03 | 292 | 7 | 2 | M41140 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-04 | 141 | 7 | 2 | b5e85f89b930a0ec70cc95733c5ab76ac3e9497f | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.39e-04 | 153 | 7 | 2 | 859de35b24c5d7d73be1c213b90b43362ee2e0eb | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 2.48e-04 | 156 | 7 | 2 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-04 | 174 | 7 | 2 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.12e-04 | 175 | 7 | 2 | 97616bb5c127284aa9e67bc336dfcf29e137164b | |
| ToppCell | BAL-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 3.19e-04 | 177 | 7 | 2 | aa021f6d62e9d740c5ea499faaf875de835a2865 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 3.19e-04 | 177 | 7 | 2 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.41e-04 | 183 | 7 | 2 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.41e-04 | 183 | 7 | 2 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | Mild-CD4+_T|World / Disease group and Cell class | 3.41e-04 | 183 | 7 | 2 | c4ac8893d38a3da4e19fe2ef1756bd69c89e975c | |
| ToppCell | Control-CD8+_T_activated|Control / Disease group and Cell class | 3.45e-04 | 184 | 7 | 2 | b86cc48b744b3206880ec1373fe6068e14bf9680 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.56e-04 | 187 | 7 | 2 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.60e-04 | 188 | 7 | 2 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.71e-04 | 191 | 7 | 2 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | CV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 3.75e-04 | 192 | 7 | 2 | 2a2052b44e8f679ef484f03ba4fb37b0ec841b88 | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.83e-04 | 194 | 7 | 2 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.87e-04 | 195 | 7 | 2 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 3.91e-04 | 196 | 7 | 2 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 3.91e-04 | 196 | 7 | 2 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | mild-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.91e-04 | 196 | 7 | 2 | ded44b38ea489946e9eedfe752b5a9fde9149c16 | |
| ToppCell | Mild|World / Disease group and Cell class | 3.91e-04 | 196 | 7 | 2 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 3.91e-04 | 196 | 7 | 2 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | CD8+_Memory_T_cell-CV-1|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.95e-04 | 197 | 7 | 2 | e59b47bccc781b2117196fe322efa87559c237c6 | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 3.95e-04 | 197 | 7 | 2 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | CV-Severe-1|Severe / Virus stimulation, Condition and Cluster | 3.99e-04 | 198 | 7 | 2 | 9b9ee0b0f6cc92e7be94869604c98f43d57ff8ff | |
| ToppCell | CV-Severe-1|CV / Virus stimulation, Condition and Cluster | 3.99e-04 | 198 | 7 | 2 | fc0e885e370ffb780eada62bb2b52065c2f8b26b | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 3.99e-04 | 198 | 7 | 2 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 4.03e-04 | 199 | 7 | 2 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 4.07e-04 | 200 | 7 | 2 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.17e-05 | 160 | 7 | 3 | 1297_UP | |
| Drug | clozapine | 5.82e-05 | 274 | 7 | 3 | CID000002818 | |
| Disease | cholelithiasis | 1.83e-04 | 88 | 7 | 2 | EFO_0004799 | |
| Disease | gallstones | 2.75e-04 | 108 | 7 | 2 | EFO_0004210 | |
| Disease | apolipoprotein A 1 measurement | 7.59e-04 | 848 | 7 | 3 | EFO_0004614 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKQISGFGKKFYYKA | 236 | P15529 | |
| FGGKYYQKAKAAFEK | 151 | Q13325 | |
| KNYFKKGLKDMGYGN | 1196 | P55265 | |
| GFSKSFKKKFFYNKK | 761 | Q8N1G2 | |
| GFYVAYKKCHGKNKA | 306 | Q12908 | |
| LKEKGNKYFKQGKYD | 136 | Q9H6T3 | |
| AAKNKGNKYFKAGKY | 116 | O94826 |